Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

TWST

Twist Bioscience Corp

May 17 • 04:00PM ET

47.01

Dollar change +0.51
Percentage change 1.10	%

Healthcare • Diagnostics & Research • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: ARKK ARKG IWM VTI VB VXF VBK IWN IBB SCHA

Index	RUT	P/E	-	EPS (ttm)	-3.35	Insider Own	4.34%	Shs Outstand	57.56M	Perf Week	10.95%
Market Cap	2.74B	Forward P/E	-	EPS next Y	-2.53	Insider Trans	-0.91%	Shs Float	55.70M	Perf Month	65.76%
Income	-192.14M	PEG	-	EPS next Q	-0.77	Inst Own	115.08%	Short Float	21.42%	Perf Quarter	14.97%
Sales	277.49M	P/S	9.86	EPS this Y	17.01%	Inst Trans	2.43%	Short Ratio	12.62	Perf Half Y	136.23%
Book/sh	9.63	P/B	4.88	EPS next Y	15.17%	ROA	-24.68%	Short Interest	11.93M	Perf Year	262.17%
Cash/sh	5.04	P/C	9.33	EPS next 5Y	-	ROE	-30.40%	52W Range	12.62 - 50.50	Perf YTD	27.54%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-6.09%	ROI	-30.26%	52W High	-6.91%	Beta	1.82
Dividend TTM	-	Quick Ratio	5.06	Sales past 5Y	60.13%	Gross Margin	38.29%	52W Low	272.50%	ATR (14)	2.47
Dividend Ex-Date	-	Current Ratio	5.51	EPS Y/Y TTM	11.09%	Oper. Margin	-68.89%	RSI (14)	69.31	Volatility	5.80% 6.52%
Employees	919	Debt/Eq	0.16	Sales Y/Y TTM	21.79%	Profit Margin	-69.24%	Recom	1.80	Target Price	43.38
Option/Short	Yes / Yes	LT Debt/Eq	0.13	EPS Q/Q	24.44%	Payout	-	Rel Volume	0.69	Prev Close	46.50
Sales Surprise	6.51%	EPS Surprise	3.15%	Sales Q/Q	25.13%	Earnings	May 02 AMC	Avg Volume	945.07K	Price	47.01
SMA20	24.38%	SMA50	33.61%	SMA200	63.44%	Trades		Volume	649,296	Change	1.10%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-17-24	Upgrade	Goldman	Neutral → Buy	$25 → $45
Sep-27-23	Initiated	Berenberg	Buy	$27
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$33
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform	$28 → $36
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral	$110
Apr-12-21	Initiated	Piper Sandler	Overweight	$150
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight	$100
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform	$90
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral	$27

Show Previous Ratings

May-13-24 08:00AM	Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications (Business Wire) +11.94%
May-10-24 06:00AM	Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life (InvestorPlace)
May-08-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-03-24 03:55PM	Sector Update: Health Care Stocks Mixed Late Afternoon (MT Newswires) +28.74%
01:58PM	Sector Update: Health Care Stocks Mixed in Afternoon Trading (MT Newswires)
01:22PM	Loading…
01:22PM	Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised (MT Newswires)
10:02AM	Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript (Insider Monkey)
06:47AM	Q2 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
04:05AM	Twist Bioscience Corp (TWST) Q2 2024 Earnings Call Transcript Highlights: Key Financial ... (GuruFocus.com)
May-02-24 09:00PM	TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
05:35PM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results (Business Wire)
Apr-30-24 03:20PM	3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition (InvestorPlace)
Apr-25-24 11:31AM	5 Fastest Growing Health Tech Companies in the World (Insider Monkey)
08:00AM	Loading…
Apr-18-24 08:00AM	Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024 (Business Wire)
Mar-28-24 08:00AM	Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations (Business Wire)
Mar-05-24 08:00AM	Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing (Business Wire)
Feb-22-24 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Feb-13-24 01:59PM	7 Stocks Cathie Wood Is Still Loading Up On in Q1 (InvestorPlace) -8.86%
Feb-10-24 05:28AM	Twist Bioscience Corp Director Robert Chess Sells 4,110 Shares (GuruFocus.com)
Feb-07-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire) -5.41%
Feb-06-24 08:05AM	Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System (Business Wire)
08:00AM	Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications (Business Wire)
Feb-05-24 08:09AM	Twist Bioscience Corporation (NASDAQ:TWST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM	Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT (Business Wire)
Feb-02-24 11:42PM	Q1 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents) +10.01%
07:55AM	Twist Bioscience Corp Reports Strong Revenue Growth in Q1 Fiscal 2024 (GuruFocus.com)
07:36AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results (Business Wire)
08:00AM	Loading…
Jan-24-24 08:00AM	Twist Bioscience Expands Express Genes Rapid Synthesis Service (Business Wire) -5.03%
Jan-16-24 08:00AM	Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024 (Business Wire)
Jan-08-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Jan-05-24 08:00AM	Twist Bioscience Appoints Adam Laponis as Chief Financial Officer (Business Wire)
Dec-19-23 12:44PM	3 Genomics Stocks to Unlock the Future of Medicine (InvestorPlace) +10.91%
Dec-18-23 08:00AM	Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-15-23 08:11AM	Twist Bioscience (TWST) Soars 12.5%: Is Further Upside Left in the Stock? (Zacks)
Nov-20-23 08:55AM	Twist Bioscience Corporation (NASDAQ:TWST) Q4 2023 Earnings Call Transcript (Insider Monkey)
Nov-18-23 01:29AM	Q4 2023 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-17-23 04:03PM	DNA-Maker Twist Bioscience Catapults 26% On 'Solid' Outlook That Tops Its Peers (Investor's Business Daily) +25.90%
08:40AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:28AM	Twist Bioscience Corp (TWST) Reports 20% Revenue Growth in Fiscal 2023 (GuruFocus.com)
07:47AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results (Business Wire)
Nov-14-23 08:00AM	Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service (Business Wire) +13.96%
Nov-13-23 08:00AM	Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference (Business Wire)
Nov-08-23 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Nov-02-23 04:05PM	Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023 (Business Wire) +10.82%
Oct-31-23 08:00AM	Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing (Business Wire)
Oct-16-23 10:43AM	16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Woods Portfolio (Insider Monkey)
Oct-06-23 12:08PM	Bayer (BAYRY) Partners Twist Bioscience for Drug Discovery (Zacks)
11:44AM	Twist Bioscience (TWST) Stock: A Hidden Value Trap? Unpacking the Risks and Rewards (GuruFocus.com)
Oct-05-23 08:00AM	Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million (Business Wire)
Oct-03-23 08:00AM	Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations (Business Wire)
Sep-27-23 08:00AM	Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases (Business Wire)
Sep-26-23 01:02PM	Twist Bioscience Corp (TWST): A Deep Dive into Its Performance Potential (GuruFocus.com) -5.20%
12:40PM	Twist Bioscience (TWST) Stock: A Hidden Value Trap? Unpacking the Risks and Rewards (GuruFocus.com)
Sep-20-23 12:11PM	Twist Bioscience Corp (TWST): A Deep Dive into Its Performance Potential (GuruFocus.com)
Sep-14-23 12:56PM	Is Twist Bioscience (TWST) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
12:31PM	Twist Bioscience Corp (TWST): A Deep Dive into Its Performance Potential (GuruFocus.com)
Sep-05-23 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Aug-31-23 03:10AM	Should You Add Twist Bioscience Corporation (TWST) to Your Portfolio? (Insider Monkey)
03:00AM	Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases (Business Wire)
Aug-22-23 08:00AM	Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene (Business Wire)
Aug-11-23 01:39PM	Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential (InvestorPlace)
Aug-07-23 09:53AM	Twist Bioscience Corporation (NASDAQ:TWST) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:00AM	Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023 (Business Wire)
Aug-04-23 01:21PM	Why Shares of Twist Bioscience Are Up Friday (Motley Fool) +11.18%
08:45AM	Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:37AM	Twist Bioscience: Fiscal Q3 Earnings Snapshot (AP Finance)
07:30AM	Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results (Business Wire)
Jul-20-23 08:00AM	Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023 (Business Wire) -10.00%
Jul-18-23 09:50AM	2 Cathie Wood Growth Stocks That Could Make You Richer (Motley Fool)
08:00AM	Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research (Business Wire)
Jun-26-23 08:10AM	Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism (Business Wire)
Jun-20-23 08:00AM	Twist Bioscience Appoints Chet Gandhi as Chief Information Officer (Business Wire)
Jun-04-23 09:46AM	We're Hopeful That Twist Bioscience (NASDAQ:TWST) Will Use Its Cash Wisely (Simply Wall St.)
May-31-23 08:00AM	Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research (Business Wire)
May-24-23 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
May-23-23 08:00AM	Twist Bioscience Appoints Robert Werner as Chief Accounting Officer (Business Wire)
May-22-23 08:00AM	Twist Bioscience Launches Portfolio of RNA Sequencing Tools (Business Wire) +14.58%
May-14-23 04:05PM	3 DNA Stocks to Buy for the Synthetic Biology Revolution (InvestorPlace)
May-10-23 08:00AM	Twist Bioscience to Present at ITF World 2023 (Business Wire)
May-08-23 08:54AM	Investors Don't See Light At End Of Twist Bioscience Corporation's (NASDAQ:TWST) Tunnel (Simply Wall St.)
May-07-23 01:18PM	Twist Bioscience Corporation (NASDAQ:TWST) Q2 2023 Earnings Call Transcript (Insider Monkey)
May-05-23 11:02AM	Why Twist Bioscience Stock Is Tumbling Today (Benzinga)
08:45AM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results (Business Wire)
May-03-23 08:45AM	Horizon Therapeutics (HZNP) Q1 Earnings and Revenues Lag Estimates (Zacks) +6.70%
May-02-23 05:53AM	3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers (Motley Fool) -7.11%
Apr-28-23 10:00AM	Twist Bioscience (TWST) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-27-23 08:00AM	Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research (Business Wire)
Apr-26-23 02:10PM	12 Gene Editing Stocks With the Best Long-Term Potential (Insider Monkey)
Apr-25-23 10:00AM	Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought (Motley Fool) -6.24%
06:35AM	The 7 Best Biotech Stocks for Personalized Medicine Investors (InvestorPlace)
Apr-20-23 06:24PM	Top 10 CRISPR Stocks To Buy (Insider Monkey) -6.11%
08:00AM	Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies (Business Wire)
Apr-13-23 08:00AM	Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies (Business Wire) +9.67%
07:59AM	Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023 (Business Wire)
Mar-29-23 04:20PM	11 Most Promising Gene Editing Stocks According to Analysts (Insider Monkey)

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Leproust Emily M.	Chief Executive Officer	May 03 '24	Sale	37.13	4,163	154,589	509,986	May 07 04:05 PM
Finn Patrick John	President and COO	May 03 '24	Sale	37.13	2,311	85,817	173,895	May 07 04:05 PM
Green Paula	SVP of Human Resources	May 03 '24	Sale	37.13	910	33,792	91,511	May 07 04:05 PM
Banyai William	See Remark	May 03 '24	Sale	37.13	798	29,633	345,188	May 07 04:05 PM
Cho Dennis	See Remarks	May 03 '24	Sale	37.13	568	21,092	80,436	May 07 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	May 03 '24	Sale	37.13	132	4,902	43,548	May 07 04:05 PM
Finn Patrick John	President and COO	Apr 23 '24	Sale	30.12	2,174	65,483	176,206	Apr 25 04:05 PM
Laponis Adam	Chief Financial Officer	Apr 09 '24	Sale	33.16	556	18,434	74,444	Apr 11 04:05 PM
Leproust Emily M.	Chief Executive Officer	Apr 02 '24	Sale	32.74	1,132	37,057	514,149	Apr 04 04:05 PM
Finn Patrick John	President and COO	Apr 02 '24	Sale	32.74	492	16,106	178,380	Apr 04 04:05 PM
Banyai William	See Remark	Apr 02 '24	Sale	32.74	327	10,705	345,986	Apr 04 04:05 PM
Green Paula	SVP of Human Resources	Apr 02 '24	Sale	32.74	229	7,497	92,421	Apr 04 04:05 PM
Cho Dennis	See Remarks	Apr 02 '24	Sale	32.74	129	4,223	81,004	Apr 04 04:05 PM
Leproust Emily M.	Chief Executive Officer	Mar 20 '24	Sale	33.52	1,128	37,806	515,281	Mar 22 04:05 PM
Banyai William	See Remark	Mar 20 '24	Sale	33.52	442	14,814	346,313	Mar 22 04:05 PM
Cho Dennis	See Remarks	Mar 20 '24	Sale	33.52	230	7,709	81,133	Mar 22 04:05 PM
Green Paula	SVP of Human Resources	Mar 20 '24	Sale	33.52	200	6,703	92,650	Mar 22 04:05 PM
Cho Dennis	See Remarks	Mar 14 '24	Sale	34.60	93	3,218	81,363	Mar 18 04:05 PM
Leproust Emily M.	Chief Executive Officer	Mar 06 '24	Sale	37.43	1,487	55,658	516,409	Mar 08 04:05 PM
Green Paula	SVP of Human Resources	Mar 06 '24	Sale	37.43	600	22,458	92,850	Mar 08 04:05 PM
Banyai William	See Remark	Mar 06 '24	Sale	37.43	549	20,549	346,755	Mar 08 04:05 PM
Cho Dennis	See Remarks	Mar 06 '24	Sale	37.43	272	10,181	81,456	Mar 08 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Mar 06 '24	Sale	37.43	181	6,775	43,680	Mar 08 04:05 PM
CHESS ROBERT	Director	Feb 08 '24	Sale	34.98	4,110	143,784	64,169	Feb 09 04:10 PM
THORBURN JAMES M	Chief Financial Officer	May 23 '23	Option Exercise	11.59	13,324	154,425	62,042	May 25 04:05 PM

Open in Screener

NKTR

Nektar Therapeutics

May 17 • 04:00PM ET

1.75

Dollar change -0.04
Percentage change -2.50	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF SCHA PRFZ VHT SCHB NANC

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	3.09%	Shs Outstand	191.38M	Perf Week	-0.28%
Market Cap	322.25M	Forward P/E	-	EPS next Y	-0.76	Insider Trans	-2.23%	Shs Float	177.94M	Perf Month	32.95%
Income	-175.84M	PEG	-	EPS next Q	-0.20	Inst Own	59.71%	Short Float	1.99%	Perf Quarter	146.52%
Sales	90.17M	P/S	3.57	EPS this Y	44.31%	Inst Trans	-4.28%	Short Ratio	1.37	Perf Half Y	234.29%
Book/sh	0.69	P/B	2.54	EPS next Y	5.57%	ROA	-36.72%	Short Interest	3.54M	Perf Year	150.71%
Cash/sh	1.58	P/C	1.11	EPS next 5Y	-7.30%	ROE	-95.68%	52W Range	0.41 - 1.93	Perf YTD	210.62%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-51.83%	52W High	-8.97%	Beta	0.80
Dividend TTM	-	Quick Ratio	5.79	Sales past 5Y	-20.42%	Gross Margin	60.91%	52W Low	325.35%	ATR (14)	0.15
Dividend Ex-Date	-	Current Ratio	6.10	EPS Y/Y TTM	58.37%	Oper. Margin	-147.13%	RSI (14)	61.96	Volatility	7.08% 9.30%
Employees	137	Debt/Eq	1.83	Sales Y/Y TTM	1.51%	Profit Margin	-195.02%	Recom	3.00	Target Price	3.30
Option/Short	Yes / Yes	LT Debt/Eq	1.68	EPS Q/Q	73.95%	Payout	-	Rel Volume	0.44	Prev Close	1.80
Sales Surprise	41.05%	EPS Surprise	0.00%	Sales Q/Q	0.21%	Earnings	May 09 AMC	Avg Volume	2.59M	Price	1.75
SMA20	12.68%	SMA50	37.74%	SMA200	129.79%	Trades		Volume	1,142,517	Change	-2.50%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Resumed	JP Morgan	Underweight
Nov-09-23	Upgrade	TD Cowen	Market Perform → Outperform
May-10-23	Upgrade	Jefferies	Underperform → Hold	$1.50 → $1
Feb-24-23	Downgrade	Jefferies	Hold → Underperform	$3.20 → $1.50
Aug-08-22	Downgrade	JP Morgan	Neutral → Underweight
May-31-22	Resumed	Jefferies	Hold	$12 → $4
Apr-18-22	Downgrade	Goldman	Neutral → Sell	$3
Mar-15-22	Downgrade	Mizuho	Buy → Neutral	$35 → $8
Mar-15-22	Downgrade	Cowen	Outperform → Market Perform
Mar-14-22	Downgrade	William Blair	Outperform → Mkt Perform
Mar-14-22	Downgrade	Stifel	Buy → Hold	$24 → $5
Mar-14-22	Downgrade	BTIG Research	Buy → Neutral
Mar-14-22	Downgrade	BofA Securities	Neutral → Underperform	$18 → $6
Mar-09-22	Upgrade	Oppenheimer	Perform → Outperform	$21
Nov-08-21	Upgrade	The Benchmark Company	Hold → Buy	$20
Sep-10-21	Initiated	BofA Securities	Neutral	$18
Jun-28-21	Upgrade	Stifel	Hold → Buy	$22 → $24
May-18-21	Resumed	Goldman	Neutral	$24
Feb-22-21	Downgrade	The Benchmark Company	Buy → Hold
Jan-06-21	Initiated	Stifel	Hold	$18

Show Previous Ratings

May-10-24 04:41PM	Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript (Insider Monkey) +10.00%
03:14PM	Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview (GuruFocus.com)
11:33AM	Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates (Zacks)
10:35AM	Q1 2024 Nektar Therapeutics Earnings Call (Thomson Reuters StreetEvents)
May-09-24 05:39PM	Nektar: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Loading…
04:15PM	Nektar Therapeutics Reports First Quarter 2024 Financial Results (PR Newswire)
May-02-24 06:00PM	Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets (PR Newswire)
Apr-03-24 11:30AM	Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue? (Zacks) +9.47%
Mar-25-24 10:00AM	DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-22-24 02:00PM	Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference (PR Newswire)
Mar-06-24 12:33PM	Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata (Zacks)
Mar-05-24 10:07AM	Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat (Zacks)
09:13AM	Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:00AM	Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata (PR Newswire)
07:19AM	Q4 2023 Nektar Therapeutics Earnings Call (Thomson Reuters StreetEvents)
05:30PM	Loading…
Mar-04-24 05:30PM	Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +15.38%
04:51PM	Nektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Results (GuruFocus.com)
04:42PM	Nektar: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results (PR Newswire)
08:30AM	Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX (PR Newswire)
Feb-27-24 06:00PM	Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference (PR Newswire) +11.94%
Feb-26-24 06:00PM	Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets (PR Newswire)
Feb-20-24 10:00AM	Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know (Zacks) -6.78%
Jan-03-24 06:00PM	Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA (PR Newswire) -6.36%
Dec-11-23 06:00PM	Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting (PR Newswire)
Dec-07-23 11:31AM	Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-09-23 08:39AM	Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.00%
Nov-08-23 11:47AM	Nektar Therapeutics (NKTR) Incurs Wider-Than-Expected Q3 Loss (Zacks) -8.76%
Nov-07-23 05:28PM	Nektar: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Nektar Therapeutics Reports Third Quarter 2023 Financial Results (PR Newswire)
06:00PM	Loading…
Oct-31-23 06:00PM	Nektar to Announce Financial Results for the Third Quarter 2023 on Tuesday, November 7, 2023, After Close of U.S.-Based Financial Markets (PR Newswire)
Oct-26-23 10:02AM	Nektar Therapeutics (NKTR) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-23-23 10:08AM	12 Best Penny Stocks to Buy Under $1 (Insider Monkey) -7.11%
Oct-13-23 08:30AM	Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress (PR Newswire)
Oct-02-23 09:00AM	Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy (PR Newswire)
Sep-27-23 09:00AM	Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate NKTR-255 in Combination with C-TIL051 in Advanced Non-Small Cell Lung Cancer (PR Newswire)
Sep-14-23 07:54AM	Nektar (NKTR) Up on Positive New Data From Eczema Study (Zacks)
Sep-13-23 09:00AM	Nektar Therapeutics Announces Promising New Data from Phase 1b Study of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis (PR Newswire)
Sep-07-23 11:31AM	Why Is Nektar (NKTR) Down 37.1% Since Last Earnings Report? (Zacks)
Sep-06-23 06:00PM	Nektar Therapeutics to Host Virtual Investor & Analyst Event with Dermatology Experts on September 13th (PR Newswire)
Aug-17-23 07:02PM	RA Capital Management, L.P. Acquires Significant Stake in Nektar Therapeutics (GuruFocus.com) -6.26%
Aug-09-23 09:25AM	Nektar Therapeutics (NKTR) Q2 Loss Narrows, Sales Miss (Zacks) -8.94%
Aug-08-23 05:30PM	Nektar Therapeutics (NKTR) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:23PM	Nektar: Q2 Earnings Snapshot (AP Finance)
04:15PM	Nektar Therapeutics Reports Second Quarter 2023 Financial Results (PR Newswire)
11:08AM	Nektar Therapeutics sues Lilly for breach of contract around skin drug (American City Business Journals)
Aug-07-23 10:23AM	Nektar Therapeutics sues Eli Lilly over autoimmune disease treatment (Reuters) +91.51%
06:30AM	Nektar Announces Promising New and Corrected Rezpegaldesleukin Efficacy Data Which Were Previously Reported in 2022 and Incorrectly Calculated by Former Collaborator Eli Lilly & Company (PR Newswire)
Aug-01-23 06:00PM	Nektar to Announce Financial Results for the Second Quarter 2023 on Tuesday, August 8, 2023, After Close of U.S.-Based Financial Markets (PR Newswire)
Jul-24-23 03:48AM	Zoetis (ZTS) Moves 6.9% Higher: Will This Strength Last? (Zacks) -5.69%
Jul-16-23 08:49AM	Nektar Therapeutics (NASDAQ:NKTR) is largely controlled by institutional shareholders who own 70% of the company (Simply Wall St.)
Jun-12-23 06:00PM	Nektar Therapeutics to Participate in Fireside Chat at the Goldman Sachs 44th Annual Global Healthcare Conference (PR Newswire)
Jun-08-23 12:55PM	Investors Don't See Light At End Of Nektar Therapeutics' (NASDAQ:NKTR) Tunnel (Simply Wall St.)
11:31AM	Why Is Nektar (NKTR) Down 19.7% Since Last Earnings Report? (Zacks)
May-10-23 11:28AM	Nektar Therapeutics (NASDAQ:NKTR) Q1 2023 Earnings Call Transcript (Insider Monkey)
09:16AM	Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat (Zacks)
May-09-23 06:45PM	Nektar Therapeutics (NKTR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:41PM	Nektar: Q1 Earnings Snapshot (AP Finance)
04:15PM	Nektar Therapeutics Reports First Quarter 2023 Financial Results (PR Newswire)
May-08-23 09:29AM	Biotech Stocks' Q1 Earnings on May 9: NVAX, EBS & More (Zacks) -5.94%
May-04-23 10:00AM	Earnings Preview: Marinus Pharmaceuticals (MRNS) Q1 Earnings Expected to Decline (Zacks)
May-02-23 10:01AM	Will Nektar Therapeutics (NKTR) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-27-23 08:30AM	Nektar Therapeutics Announces It Will Regain Full Rights to Rezpegaldesleukin (REZPEG, NKTR-358), a Novel, First-in-Class Selective Regulatory T-cell (Treg) Therapy in Clinical Development (PR Newswire)
Apr-19-23 08:38AM	Zacks.com featured highlights include Disney, Casey's General Stores, OpGen, Accelerate Diagnostics and Nektar Therapeutics (Zacks)
Apr-17-23 05:00PM	Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan (PR Newswire) +6.26%
Apr-16-23 06:30AM	7 Sorry Pharma Stocks to Sell in April Before Its Too Late (InvestorPlace)
Apr-13-23 10:59AM	Here's Why You May Add Nektar (NKTR) Stock to Your Portfolio (Zacks) +10.16%
Apr-11-23 08:57AM	Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, KalVista Pharmaceuticals, Larimar Therapeutics, Nektar Therapeutics and Jounce Therapeutics (Zacks) +10.53%
Apr-10-23 10:07AM	5 Stocks to Buy as the Drug Industry Rebounds in 2023 (Zacks) +6.57%
Apr-02-23 08:27AM	We Think Nektar Therapeutics (NASDAQ:NKTR) Needs To Drive Business Growth Carefully (Simply Wall St.)
Mar-30-23 11:30AM	Why Is Nektar (NKTR) Down 51.9% Since Last Earnings Report? (Zacks) -12.42%
Mar-29-23 05:44PM	Crane Set to Join S&P MidCap 400; PacWest Bancorp to Join S&P SmallCap 600 (PR Newswire)
Mar-24-23 12:00PM	Nektar (NKTR) Upgraded to Buy: Here's Why (Zacks)
Mar-22-23 09:35AM	Down -69.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Nektar (NKTR) (Zacks) -9.73%
Mar-14-23 03:43AM	Sage Therapeutics, Inc. (SAGE) Soars 9.6%: Is Further Upside Left in the Stock? (Zacks)
Feb-28-23 05:15PM	Nektar Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results (PR Newswire)
Feb-24-23 10:23AM	Why Nektar Therapeutics Stock Is Plunging Today (Benzinga) -49.66%
07:29AM	Boeing stock slips after deliveries of 787s halted; Beyond Meat shares rally after plant-food makers results (MarketWatch)
Feb-23-23 06:20PM	UPDATE 1-Nektar Therapeutics' autoimmune disease drug fails mid-stage study (Reuters)
05:24PM	Nektar stock drops more than 30% after study involving lupus treatment will not go forward (MarketWatch)
04:30PM	Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus (PR Newswire)
Jan-09-23 09:04AM	Concert (CNCE) Moves 19.3% Higher: Will This Strength Last? (Zacks)
Jan-04-23 09:00AM	Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA (PR Newswire) +6.85%
Dec-12-22 10:05AM	Nektar Announces Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting (PR Newswire)
Dec-05-22 08:00AM	Nektar Therapeutics to Host Investor & Analyst Event on December 12th (PR Newswire)
Nov-10-22 09:05AM	Nektar Therapeutics Presents Preclinical Data from Novel PEGylated Interferon Gamma Program, NKTR-288, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire) +8.66%
07:58AM	Nektar Therapeutics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-09-22 09:00AM	Nektar and Collaborators Announce Publication in Blood Advances of Preclinical Data Demonstrating NKTR-255, a Novel Polymer-conjugated Human IL-15, Improves Efficacy of CD19-targeted CAR-T Cell Immunotherapy (PR Newswire) -5.54%
Nov-04-22 12:35PM	Nektar's (NKTR) Q3 Earnings and Revenues Beat Estimates (Zacks) +5.90%
Nov-03-22 06:35PM	Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Oct-28-22 10:00AM	ImmunoGen (IMGN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-27-22 10:02AM	Nektar Therapeutics (NKTR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-25-22 06:00PM	Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets (PR Newswire)
Oct-24-22 07:55AM	Here's Why We're Watching Nektar Therapeutics' (NASDAQ:NKTR) Cash Burn Situation (Simply Wall St.)
Oct-11-22 05:13PM	Why a S.F. biotech and its potential merger partner pulled the plug on talks (American City Business Journals)
Oct-07-22 03:42PM	Longtime S.F. biotech in talks with London company on 'combination' (American City Business Journals)
11:21AM	PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics (Benzinga)
Sep-07-22 01:15AM	Nektar Therapeutics Presents Data for Rezpegaldesleukin (LY3471851) in Patients with Atopic Dermatitis and Psoriasis from Two Separate Clinical Studies at 2022 European Academy of Dermatology (EADV) Congress (PR Newswire)
Aug-21-22 09:57AM	Nektar Therapeutics (NASDAQ:NKTR shareholders incur further losses as stock declines 11% this week, taking five-year losses to 75% (Simply Wall St.)
Aug-16-22 08:30AM	Nektar and Collaborators Announce Preclinical Publication of Data for NKTR-255 and its Observed Improvement of NK Cell Function in Multiple Myeloma (PR Newswire)

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Deep Track Capital, LP	10% Owner	May 10 '24	Sale	1.78	56,000	99,630	18,344,000	May 13 04:36 PM
ROBIN HOWARD W	President & CEO	Feb 20 '24	Sale	0.68	20,033	13,622	879,889	Feb 22 08:16 PM
Zalevsky Jonathan	Chief R&D Officer	Feb 20 '24	Sale	0.68	9,014	6,130	265,025	Feb 22 08:19 PM
Wilson Mark Andrew	Chief Legal Officer	Feb 20 '24	Sale	0.68	7,606	5,172	236,674	Feb 22 08:17 PM
ROBIN HOWARD W	President & CEO	Nov 17 '23	Sale	0.49	19,877	9,740	899,922	Nov 20 08:58 PM
Zalevsky Jonathan	Chief R&D Officer	Nov 17 '23	Sale	0.49	9,646	4,727	274,039	Nov 20 09:02 PM
Wilson Mark Andrew	Chief Legal Officer	Nov 17 '23	Sale	0.49	7,179	3,518	243,780	Nov 20 09:00 PM
Curet Myriam	Director	Sep 18 '23	Sale	0.69	4,359	3,008	27,418	Sep 20 08:09 PM
Ajer Jeffrey Robert	Director	Sep 18 '23	Sale	0.69	4,359	3,008	34,153	Sep 20 08:06 PM
ROBIN HOWARD W	President & CEO	Aug 16 '23	Sale	0.78	19,998	15,598	919,799	Aug 17 08:06 PM
Zalevsky Jonathan	Chief R&D Officer	Aug 16 '23	Sale	0.78	9,703	7,568	283,685	Aug 17 08:08 PM
Wilson Mark Andrew	Chief Legal Officer	Aug 16 '23	Sale	0.78	7,221	5,632	250,959	Aug 17 08:07 PM
WHITFIELD ROY A	Director	Jun 14 '23	Sale	0.57	30,000	17,100	216,250	Jun 15 06:26 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

TWST

Twist Bioscience Corp

NKTR

Nektar Therapeutics

Upgrade your FINVIZ experience